Apellis Pharmaceuticals I... (APLS)
18.20
0.04 (0.22%)
At close: Apr 17, 2025, 3:59 PM
18.55
1.92%
After-hours: Apr 17, 2025, 04:32 PM EDT
Apellis Pharmaceuticals Revenue
Apellis Pharmaceuticals reported an annual revenue of $709.95M, reflecting a 79.01% growth. For the quarter ending December 31, 2024, Apellis Pharmaceuticals generated $212.53M in revenue.
Revenue (ttm)
$709.95M
Revenue Growth
79.01%
Price / Sales Ratio
5.57
Revenue / Employee
$1.01M
Employees
705
Market Cap
2.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 709.95M | +79.01% |
| Dec 31, 2023 | 396.59M | +425.83% |
| Dec 31, 2022 | 75.42M | +13.31% |
| Dec 31, 2021 | 66.56M | -73.44% |
| Dec 31, 2020 | 250.65M | n/a |